Patrick J. Zenner, Director at SCIELE PHARMA, INC. (SCRX), sold 9,200 shares at $21.46 ($195K) on 2006-11-08, disclosed to the SEC on 2006-11-09.
Open-market sale of $195k SCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.91 | 4,600 | $96K | 49.4% |
| 2 | $21.46 | 800 | $17K | 8.8% |
| 3 | $21.46 | 3,800 | $82K | 41.8% |
| Total | $21.18 avg | 9,200 | $195K | 100% |
| Filing → |
| WST | BUY | 2018-05-17 | $24K | — | Filing → |
| ARQL | BUY | 2018-05-15 | $25K | — | Filing → |
| WST | BUY | 2016-12-09 | $28K | — | Filing → |